Femasy announces that it has received CE mark certification and product approval from Health Canada, the Public Health Agency of Canada, for its compact, eco-friendly FemVue MINI for fallopian tube assessment. “Our mission at Femasys has always been to develop cutting-edge technology that are safe, affordable, and accessible to address critical needs in women’s health,” said Kathy Lee-Sepsick, Femasys’ Founder, President, and CEO. “With the FemVue MINI, we are advancing an equally effective solution in a smaller footprint that is aligned with our initiative to be environmentally conscious demonstrating our commitment to sustainability.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
- Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
- Femasys hosts Congresswoman Lucy McBath at Georgia headquarters
- Femasys price target lowered to $10 from $12 at Chardan
- Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update